Obesity-Associated Autoantibody Production Requires AIM to Retain the Immunoglobulin M Immune Complex on Follicular Dendritic Cells

Cell Reports

Volumn 3, Issue 4, 2013, Pages 1187-1198

  Arai, Satoko ^a   Maehara, Natsumi ^a   Iwamura, Yoshihiro ^a   Honda, Shin ichiro ^b   Nakashima, Katsuhiko ^a   Kai, Toshihiro ^a   Ogishi, Masato ^a   Morita, Kumiko ^a   Kurokawa, Jun ^a   Mori, Mayumi ^a   Motoi, Yuji ^c   Miyake, Kensuke ^c   Matsuhashi, Nobuyuki ^d   Yamamura, Ken ichi ^e   Ohara, Osamu ^f   Shibuya, Akira ^b   Wakeland, Edward K ^g   Li, Quan Zhen ^h   Miyazaki, Toru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Kanto Teishin Hospital   (Japan)

^e KUMAMOTO UNIVERSITY   (Japan)

^f KAZUSA DNA RESEARCH INSTITUTE   (Japan)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; APOPTOSIS INHIBITOR OF MACROPHAGE; AUTOANTIBODY; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; FC RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; POLYCLONAL ANTIBODY; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL INTERACTION; CONTROLLED STUDY; FOLLICULAR DENDRITIC CELL; HELPER CELL; HUMAN; IMMUNOBLOTTING; LIPID DIET; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BINDING; URINARY EXCRETION;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; APOPTOSIS REGULATORY PROTEINS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; DENDRITIC CELLS, FOLLICULAR; DIET, HIGH-FAT; HEK293 CELLS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; MICE, KNOCKOUT; MICE, OBESE; OBESITY; PLASMA CELLS; PROTEIN BINDING; RECEPTORS, FC; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTOR 4;

MUS;

EID: 84877004146     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.03.006     Document Type: Article

References (65)

1. Ahearn J.M., Fearon D.T. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 1989, 46:183-219.
2. Allen C.D., Cyster J.G. Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. Semin. Immunol. 2008, 20:14-25.
3. Arai S., Shelton J.M., Chen M., Bradley M.N., Castrillo A., Bookout A.L., Mak P.A., Edwards P.A., Mangelsdorf D.J., Tontonoz P., Miyazaki T. A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab. 2005, 1:201-213.
4. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., Harley J.B. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 2003, 349:1526-1533.
5. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., Wynshaw-Boris A., Poli G., Olefsky J., Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 2005, 11:191-198.
6. Badaru A., Pihoker C. Type 2 diabetes in childhood: clinical characteristics and role of β-cell autoimmunity. Curr. Diab. Rep. 2012, 12:75-81.
7. Boes M. Role of natural and immune IgM antibodies in immune responses. Mol. Immunol. 2000, 37:1141-1149.
8. Boes M., Esau C., Fischer M.B., Schmidt T., Carroll M., Chen J. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 1998, 160:4776-4787.
9. Cambuli V.M., Incani M., Cossu E., Congiu T., Scano F., Pilia S., Sentinelli F., Tiberti C., Cavallo M.G., Loche S., Baroni M.G. Prevalence of type 1 diabetes autoantibodies (GADA, IA2, and IAA) in overweight and obese children. Diabetes Care 2010, 33:820-822.
10. Carroll M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 1998, 16:545-568.
11. Cyster J.G. B cell follicles and antigen encounters of the third kind. Nat. Immunol. 2010, 11:989-996.
12. Erlandsson L., Andersson K., Sigvardsson M., Lycke N., Leanderson T. Mice with an inactivated joining chain locus have perturbed IgM secretion. Eur. J. Immunol. 1998, 28:2355-2365.
13. Fairhurst A.M., Wandstrat A.E., Wakeland E.K. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv. Immunol. 2006, 92:1-69.
14. Hardy R.R., Hayakawa K. CD5 B cells, a fetal B cell lineage. Adv. Immunol. 1994, 55:297-339.
15. Hersoug L.G., Linneberg A. The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance?. Allergy 2007, 62:1205-1213.
16. Heyman B. The immune complex: possible ways of regulating the antibody response. Immunol. Today 1990, 11:310-313.
17. Honda S., Kurita N., Miyamoto A., Cho Y., Usui K., Takeshita K., Takahashi S., Yasui T., Kikutani H., Kinoshita T., et al. Enhanced humoral immune responses against T-independent antigens in Fc alpha/muR-deficient mice. Proc. Natl. Acad. Sci. USA 2009, 106:11230-11235.
18. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
19. Iwamura Y., Mori M., Nakashima K., Mikami T., Murayama K., Arai S., Miyazaki T. Apoptosis inhibitor of macrophage (AIM) diminishes lipid droplet-coating proteins leading to lipolysis in adipocytes. Biochem. Biophys. Res. Commun. 2012, 422:476-481.
20. Joseph S.B., Bradley M.N., Castrillo A., Bruhn K.W., Mak P.A., Pei L., Hogenesch J., O'connell R.M., Cheng G., Saez E., et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 2004, 119:299-309.
21. Kantor A.B., Herzenberg L.A. Origin of murine B cell lineages. Annu. Rev. Immunol. 1993, 11:501-538.
22. King C., Tangye S.G., Mackay C.R. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 2008, 26:741-766.
23. Kurokawa J., Arai S., Nakashima K., Nagano H., Nishijima A., Miyata K., Ose R., Mori M., Kubota N., Kadowaki T., et al. Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. Cell Metab. 2010, 11:479-492.
24. Kurokawa J., Nagano H., Ohara O., Kubota N., Kadowaki T., Arai S., Miyazaki T. Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue. Proc. Natl. Acad. Sci. USA 2011, 108:12072-12077.
25. Li Q.Z., Xie C., Wu T., Mackay M., Aranow C., Putterman C., Mohan C. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J. Clin. Invest. 2005, 115:3428-3439.
26. Li Q.Z., Zhou J., Wandstrat A.E., Carr-Johnson F., Branch V., Karp D.R., Mohan C., Wakeland E.K., Olsen N.J. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin. Exp. Immunol. 2007, 147:60-70.
27. Li Q.Z., Zhou J., Lian Y., Zhang B., Branch V.K., Carr-Johnson F., Karp D.R., Mohan C., Wakeland E.K., Olsen N.J. Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes. Clin. Exp. Immunol. 2010, 159:281-291.
28. Lopes-Carvalho T., Kearney J.F. Development and selection of marginal zone B cells. Immunol. Rev. 2004, 197:192-205.
29. MacLennan I.C., Gray D., Kumararatne D.S., Bazin H. The lymphocytes of splenic marginal zones: a distinct B-cell lineage. Immunol. Today 1982, 3:305-307.
30. Marzullo P., Minocci A., Tagliaferri M.A., Guzzaloni G., Di Blasio A., De Medici C., Aimaretti G., Liuzzi A. Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants. J. Clin. Endocrinol. Metab. 2010, 95:3965-3972.
31. McHeyzer-Williams M., Okitsu S., Wang N., McHeyzer-Williams L. Molecular programming of B cell memory. Nat. Rev. Immunol. 2012, 12:24-34.
32. Menahan L.A. Age-related changes in lipid and carbohydrate metabolism of the genetically obese mouse. Metabolism 1983, 32:172-178.
33. Meyer-Bahlburg A., Bandaranayake A.D., Andrews S.F., Rawlings D.J. Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals. J. Immunol. 2009, 182:4065-4075.
34. Miyazaki T., Hirokami Y., Matsuhashi N., Takatsuka H., Naito M. Increased susceptibility of thymocytes to apoptosis in mice lacking AIM, a novel murine macrophage-derived soluble factor belonging to the scavenger receptor cysteine-rich domain superfamily. J. Exp. Med. 1999, 189:413-422.
35. Miyazaki T., Kurokawa J., Arai S. AIMing at metabolic syndrome. -Towards the development of novel therapies for metabolic diseases via apoptosis inhibitor of macrophage (AIM). Circ. J. 2011, 75:2522-2531.
36. Mohan C., Morel L., Yang P., Watanabe H., Croker B.P., Gilkeson G.S., Wakeland E.K. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J. Clin. Invest. 1999, 103:1685-1695.
37. Morel L., Mohan C., Yu Y., Croker B.P., Tian N., Deng A., Wakeland E.K. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J. Immunol. 1997, 158:6019-6028.
38. Morel L., Croker B.P., Blenman K.R., Mohan C., Huang G., Gilkeson G., Wakeland E.K. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. USA 2000, 97:6670-6675.
39. Mori M., Kimura H., Iwamura Y., Arai S., Miyazaki T. Modification of N-glycosylation modulates the secretion and lipolytic function of apoptosis inhibitor of macrophage (AIM). FEBS Lett. 2012, 586:3569-3574.
40. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
41. Neels J.G., Olefsky J.M. Inflamed fat: what starts the fire?. J. Clin. Invest. 2006, 116:33-35.
42. Notley C.A., Baker N., Ehrenstein M.R. Secreted IgM enhances B cell receptor signaling and promotes splenic but impairs peritoneal B cell survival. J. Immunol. 2010, 184:3386-3393.
43. Oliver A.M., Martin F., Kearney J.F. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 1999, 162:7198-7207.
44. Pepys M.B. Role of complement in the induction of immunological responses. Transplant. Rev. 1976, 32:93-120.
45. Pillai S., Cariappa A., Moran S.T. Marginal zone B cells. Annu. Rev. Immunol. 2005, 23:161-196.
46. Rosenbloom A.L. Obesity, Insulin Resistance, beta-Cell Autoimmunity, and the Changing Clinical Epidemiology of Childhood Diabetes. Diabetes Care 2003, 26:2954-2956.
47. Shapiro-Shelef M., Calame K. Regulation of plasma-cell development. Nat. Rev. Immunol. 2005, 5:230-242.
48. Shi X., Xie C., Kreska D., Richardson J.A., Mohan C. Genetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity. J. Exp. Med. 2002, 196:281-292.
49. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 116:3015-3025.
50. Shibuya A., Sakamoto N., Shimizu Y., Shibuya K., Osawa M., Hiroyama T., Eyre H.J., Sutherland G.R., Endo Y., Fujita T., et al. Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat. Immunol. 2000, 1:441-446.
51. Shmerling R.H. Autoantibodies in systemic lupus erythematosus-there before you know it. N. Engl. J. Med. 2003, 349:1499-1500.
52. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J. Clin. Invest. 2006, 116:1793-1801.
53. Solinas G., Vilcu C., Neels J.G., Bandyopadhyay G.K., Luo J.L., Naugler W., Grivennikov S., Wynshaw-Boris A., Scadeng M., Olefsky J.M., Karin M. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 2007, 6:386-397.
54. Subramanian S., Yim Y.S., Liu K., Tus K., Zhou X.J., Wakeland E.K. Epistatic suppression of systemic lupus erythematosus: fine mapping of Sles1 to less than 1 mb. J. Immunol. 2005, 175:1062-1072.
55. Tissot J.D., Sanchez J.C., Vuadens F., Scherl A., Schifferli J.A., Hochstrasser D.F., Schneider P., Duchosal M.A. IgM are associated to Sp alpha (CD5 antigen-like). Electrophoresis 2002, 23:1203-1206.
56. Underhill G.H., Minges Wols H.A., Fornek J.L., Witte P.L., Kansas G.S. IgG plasma cells display a unique spectrum of leukocyte adhesion and homing molecules. Blood 2002, 99:2905-2912.
57. Usui K., Honda S., Yoshizawa Y., Nakahashi-Oda C., Tahara-Hanaoka S., Shibuya K., Shibuya A. Isolation and characterization of naïve follicular dendritic cells. Mol. Immunol. 2012, 50:172-176.
58. Valledor A.F., Hsu L.C., Ogawa S., Sawka-Verhelle D., Karin M., Glass C.K. Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc. Natl. Acad. Sci. USA 2004, 101:17813-17818.
59. Vinuesa C.G., Linterman M.A., Goodnow C.C., Randall K.L. T cells and follicular dendritic cells in germinal center B-cell formation and selection. Immunol. Rev. 2010, 237:72-89.
60. Vogelzang A., McGuire H.M., Yu D., Sprent J., Mackay C.R., King C. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 2008, 29:127-137.
61. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
62. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 2003, 112:1785-1788.
63. Winer D.A., Winer S., Shen L., Wadia P.P., Yantha J., Paltser G., Tsui H., Wu P., Davidson M.G., Alonso M.N., et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 2011, 17:610-617.
64. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112:1821-1830.
65. Zotos D., Tarlinton D.M. Determining germinal centre B cell fate. Trends Immunol. 2012, 33:281-288.